BioCentury
ARTICLE | Company News

Uluru, Melmed Holdings sales and marketing update

December 19, 2011 8:00 AM UTC

The companies added Australia and New Zealand to an October letter of intent granting an undisclosed Melmed subsidiary exclusive rights to commercialize Altrazeal in the EU. The deal has not been fin...